Tata India Pharma & Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8357 Cr | ₹1309 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | Nifty Pharma TRI |
Turn Over | 21% | 26.49% |
Expense Ratio | 1.82 | 2.14 |
Manager | Sailesh Raj Bhan | Meeta Shetty |
ISIN Code | INF204K01968 | INF277K016A9 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -0.21% | -0.44% |
6 Month | 10.3% | 12.19% |
1 Year | -1.03% | -1.57% |
3 Year | 23.87% | 24.28% |
5 Year | 18.01% | 18.06% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 2.85% | 3.9% |
1 Year | 8% | 9.27% |
3 Year | 21.14% | 22.51% |
5 Year | 18.27% | 19.09% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 17.31% | 10.55% |
3 Year | 20.52% | 18.34% |
5 Year | 20.64% | 15.18% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.03% | 15.94% |
Sharp | 1.00% | 0.99% |
Beta | 0.91% | 0.98% |
Alpha | 0.32% | -0.12% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Meeta Shetty |
Total AUM | ₹96086 Cr | ₹17847 Cr |
Funds Managed | 5 | 5 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.56 | 4.61 |
Large Cap | 34.91 | 28.41 |
Mid Cap | 32.08 | 35.03 |
Small Cap | 31.46 | 31.95 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 0.52 | 2.56 |
Healthcare | 99.48 | 94.45 |
Basic Materials | - | 1.44 |
Financial Services | - | 1.56 |
Top Comparisons
Motilal Oswal Balance Advantage Fund (MOFDYNAMIC) - Regular Plan - Growth Option
3Y Returns9.85%
Edelweiss Balanced Advantage Fund - Regular Plan - Growth Option
3Y Returns12.26%
Edelweiss Overnight Fund - Regular Plan - Growth
3Y Returns6.35%
Canara Robeco Overnight Fund - Regular Plan - Growth Option
3Y Returns6.37%
Aditya Birla Sun Life Corporate Bond Fund - Growth - Regular Plan
3Y Returns7.72%
DSP Corporate Bond Fund - Regular - Growth
3Y Returns7.25%
WhiteOak Capital Large Cap Fund Regular Plan Growth
3Y Returns0%
DSP Large Cap Fund - Regular Plan - Growth
3Y Returns18.07%